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Internal Medicine Consultation
for Dentists
Nina Mingioni, MD FACP
Internal Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Gerteis J, Izrael D, Deitz D, LeRoy L, Ricciardi R, Miller T, Basu J. Multiple Chronic Conditions Chartbook. AHRQ 
Publications No, Q14-0038. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. 
Learning Objectives
Recognize ubiquitous nature of common medical condition in 
general population
Discuss implications of common medical conditions on dental care 
of patients
Identify concerns affecting patients that would necessitate medical 
consultation prior to dental intervention
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Hypertension
CHRONICALLY ELEVATED BLOOD 
PRESSURE >140/90
29% OF ADULTS IN US 
(1 IN 3!!!!!)
ONLY 54% CONTROLLED
Elevated Blood Pressure in the office
Previously undiagnosed hypertension
Known hypertension
Chronically uncontrolled
Usually controlled, but uncontrolled today
White coat hypertension
Pain
What is “dangerously elevated blood pressure?”
Hypertensive Urgency
• SBP >180 and/or DBP >110
• Asymptomatic
• ?mild headache
Hypertensive Emergency
• SBP >180 and/or DBP >110
• Altered Mental Status
• Stroke (ischemic/hemorrhagic)
• Acute coronary syndrome
• Hearth failure
• Renal failure
When to send to ER?
• SBP >180 and/or DBP >110
• Altered Mental Status 
• Stroke (ischemic/hemorrhagic)
• Retinopathy
• Acute coronary syndrome
• Aortic dissection
• Hearth failure
• Renal failure
Lethargy/confusion
Neurologic deficits
Chest pain
Blood in urine
Shortness of breath
Blurry vision
What to ask your patient…
Do you have…. (ask for “red flag symptoms”)
Have you ever been told you have elevated blood pressure?
Did you take your medications today?
Do you check your blood pressure at home?
What was your blood pressure last time you went to see your doctor?

White Coat Hypertension
Diagnosis
In-office interval readings Ambulatory blood pressure monitoring
15-30% of all patients with elevated office readings
Blood pressure is consistently elevated by the office readings but does not meet diagnostic criteria 
for hypertension based on out-of-office readings
So, your patient has elevated BP…
• >180/110 – ask for “red flag symptoms”
• Present – send to ER
• Absent – send to their primary care physician
• Dental treatment should (probably) not be performed that day
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Hypoglycemia
VS
Hyperglycemia
Who gets hypoglycemia?
PATIENTS ON INSULIN PATIENTS TAKING 
SULFONYLUREA MEDICATIONS
Medications that do NOT cause hypoglycemia
Metformin TZDs GLP-1 analogues
DPP4 
inhibitors
SGLT-2 
antagonists
Pre-procedure advice: 
Patients on insulin
• Long acting insulins: glargine (Lantus/Basaglar), detemir (Levimir), 
diglutec (Tresiba) 
continue full dose without adjustments
• Patients with insulin pumps
continue full dose without adjustments
Pre-procedure advice: 
Patients on insulin
• Pre-mixed insulin: 70/30, 75/25, 50/50
HALF of usual morning dose
• Intermediate acting insulin: NHP
HALF of usual morning dose
• Short acting insulins: lispro, aspart, glulisine
NONE, unless patient is eating
What if patient is hypoglycemic?
• Glucose tablets
• Glucose gel
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Anticoagulants
Antiplatelet medications (aspirin, clopidogrel, prasugrel)
Vitamin K antagonists (warfarin)
Heparins (UFH, LMWH)
Novel oral anticoagulants
Factor Xa inhibitors: apixaban, rivaroxaban
Direct thrombin inhibitors: dabigatran
Anticoagulants: indications
• Treatment of acute event
• Primary prophylaxis
• Aspirin for heart disease, stroke prevention
• Warfarin/NOACs for stroke prophylaxis in Atrial Fibrillation
• Warfarin for stroke prophylaxis in patients after valve replacement
• Secondary prophylaxis
• Heart disease
• Strokes
• Clots
Interruption?
MOST PATIENTS -> 
CONTINUE MEDS
HIGH BLEEDING RISK -> 
TALK TO THE PRIMARY CARE DOC
Coagulopathy due to other medical conditions
Chronic kidney disease
• Dialysis patients
Chronic liver disease
Bone marrow disorders
• Myelodysplasia
• Hematologic malignancies
• Recent chemotherapy
Hereditary 
coagulopathies
Autoimmune 
(idiopathic 
thrombocytopenic 
purpura)
Advanced heart failure 
(with secondary liver 
dysfunction) 
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Would you consider antibiotic to prevent 
infections in patients with…
Prosthetic valve? Prosthetic joint? Breast implants?
Immunosuppressed? Pacemaker? Coronary stent?
Dialysis AV graft?
Endocarditis Prophylaxis: YES
Prosthetic valves History of endocarditis
Congenital heart 
disease
Unrepaired 
cyanotic heart 
disease
Cyanotic heart 
disease with repair 
that used 
prosthetic material
Hearth transplant 
recipients with 
valvulopathy
Wilson Walter, Taubert Kathryn A., Gewitz Michael, Lockhart Peter B., Baddour Larry M., Levison Matthew, Bolger Ann, Cabell Christopher H., Takahashi Masato, Baltimore Robert S., Newburger Jane W., Strom Brian L., 
Tani Lloyd Y., Gerber Michael, Bonow Robert O., Pallasch Thomas, Shulman Stanford T., Rowley Anne H., Burns Jane C., … (2007). Prevention of Infective Endocarditis. Circulation, 116(15), 1736–1754.
Antibiotic prophylaxis: how effective is it?
• No human study has definitively demonstrated that prophylactic 
antibiotics prevent endocarditis after invasive procedures
• Risk factors appear to be presence of structural heart defect, NOT the 
dental procedure
• Epidemiologic studies: less than 10% of IE is prevented by antibiotic 
prophylaxis
• Less than 5% of IE are actually preceded by a dental procedure (not a 
proof of causation)
Wilson Walter, Taubert Kathryn A., Gewitz Michael, Lockhart Peter B., Baddour Larry M., Levison Matthew, Bolger Ann, Cabell Christopher H., Takahashi Masato, Baltimore Robert S., Newburger Jane W., Strom Brian L., 
Tani Lloyd Y., Gerber Michael, Bonow Robert O., Pallasch Thomas, Shulman Stanford T., Rowley Anne H., Burns Jane C., … (2007). Prevention of Infective Endocarditis. Circulation, 116(15), 1736–1754.
Antibiotics: what’s the big deal?
development of antibiotic-resistant bacterial pathogens
C. difficile infections
Severe allergic reactions 
Costs 
malpractice litigation 
additional medical and dental office visits
Who does 
NOT
need 
antibiotic 
prophylaxis…
• Patients with pacemakers/defibrillators
• Patients with vascular grafts, including dialysis 
grafts
• Patients with endovascular grafts
• Patients with coronary stents
• Patients with Vena Cava filters
• Patients with VP shunts
• Patients with breast implants
• Patients with prosthetic joints
• Pregnant patients
May need antibiotic prophylaxis…
• Immunocompromised patients?
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Immunocompromised: what’s the big deal?
High risk of infection
Depends on degree of immunosuppression
High risk of malignancy
Immunocompromised populations
DISORDERS OF 
BIOCHEMICAL 
HOMEOSTASIS
DISORDERS OF PROTEIN 
LOSS
IMMUNOSUPPRESSIVE 
THERAPY
MALIGNANCY AUTOIMMUNE DISEASES 
(LUPUS, RHEUMATOID 
ARTHRITIS)
VIRAL INFECTIONS (HIV) ASPLENIA/HYPOSPLENISM
Disorders of biochemical homeostasis
DIABETES CHRONIC KIDNEY 
DISEASE/UREMIA
CIRRHOSIS MALNUTRITION
Disorders of protein loss
NEPHROTIC SYNDROME PROTEIN-LOSING 
ENTEROPATHIES
Immunosuppressive therapy
Cytotoxic chemotherapy for malignancy
Autoimmune disease treatment
Treatment of rejection after solid organ transplantation
Treatment/prophylaxis of graft-vs-host disease after bone marrow transplant
Malignancy
Hodgkin 
disease
Chronic 
lymphocytic 
leukemia
Multiple 
myeloma Solid tumors
Immunocompromised populations
AUTOIMMUNE DISEASES (LUPUS, 
RHEUMATOID ARTHRITIS)
VIRAL INFECTIONS (HIV) ASPLENIA/HYPOSPLENISM
Immunocompromised
• Do they need antibiotics before dental procedures?
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Bisphosphonates: indications
Osteoporosis
Sometimes: Osteopenia
Patients on chronic corticosteroids
Paget’s disease
Cancer patients with bone metastases
IV vs PO therapy: risks differ
Zolendronic acid vs placebo: 50-
100x risk of osteonecrosis 1% (1 case per 100)
Oral bisphosphonate therapy
Short term: 0.1% (1 cases per 1000)
>4 years: 0.21% (1 cases per 500)
Difference is the dose: 
Zolendronic acid dose is 10x higher than doses of PO bisphosphonates
Drug holiday? No Data!
Recommendations:
• ADA (2011): if on meds <2 years, continue during invasive dental treatment
• ONJ Task force (2013): drug holiday if >4 years on meds or risk factors (RA, 
long term steroids, DM, smoking)
• AAOMS (2014)
• Optimize dental health before IV bisphosphonates
• PO bisphosphonates <4 years and no risk factors: no holiday
• PO bisphosphonates <4years but with risk factors: 2mo holiday before, restart once 
bone heals
• PO bisphosphonates >4years: 2mo holiday before, restart once bone heals
• AACE (2016): delay initiation until dental issues are corrected. No evidence 
for drug holiday, but consider.
Bisphosphonate Drug Holiday: Summary
No Data
Consider drug 
holiday if:
On meds >4 years
Risk factors for 
osteonecrosis
All patients on 
bisphosphonates?How long???
Summary
Incidence of chronic illness increases with age
Many of your patients will have special considerations in their dental care
Know how to properly check a blood pressure, and when to send to ER
Have a source of glucose in your office
Most patients do not need anticoagulation interruption
Most patients do not need prophylactic antibiotics
Incidence of osteonecrosis in patients with PO bisphosphonates is low
When in doubt, call their primary care doctor (and have low threshold to do so)
Questions?
